Bios Lab Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 16-11-2024
- Satisfied Charges ₹ 5.00 M
as on 16-11-2024
- Revenue 18.34%
(FY 2023)
- Profit 26.02%
(FY 2023)
- Ebitda 17.79%
(FY 2023)
- Net Worth 24.91%
(FY 2023)
- Total Assets 36.76%
(FY 2023)
About Bios Lab
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Solanki, Sachin Shishangiya, and Sandip Shishangia serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC082869
- Company No.
082869
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bios Lab Private Limited offer?
Bios Lab Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Hair Growth Medicine, Patient Monitoring System, Central Patient Monitoring System, Human Anatomical Models.
Who are the key members and board of directors at Bios Lab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Solanki  | Director | 10-Apr-2015 | Current |
| Sachin Shishangiya | Director | 10-Apr-2015 | Current |
| Sandip Shishangia | Director | 10-Apr-2015 | Current |
Financial Performance of Bios Lab.
Bios Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.34% increase. The company also saw a substantial improvement in profitability, with a 26.02% increase in profit. The company's net worth Soared by an impressive increase of 24.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bios Lab?
In 2023, Bios Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioszorg Meditech Private LimitedInactive For E-Filing 4 months 19 daysBharat Solanki is a mutual person
- Ai Sante Meditech Private LimitedInactive For E-Filing 4 months 19 days
Bharat Solanki is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Oct 2022 | ₹3.00 M | Open |
Others Creation Date: 24 Jun 2021 | ₹1.50 M | Open |
Others Creation Date: 07 May 2015 | ₹5.00 M | Satisfied |
How Many Employees Work at Bios Lab?
Bios Lab has a workforce of 57 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bios Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bios Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
